• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    MetLife Announces New $3 Billion Share Repurchase Authorization

    4/30/25 4:14:00 PM ET
    $MET
    Life Insurance
    Finance
    Get the next $MET alert in real time by email

    MetLife, Inc. (NYSE:MET) today announced that its board of directors has approved a new $3 billion authorization for the company to repurchase its common stock. The new authorization is incremental to the approximately $360 million remaining under the company's prior authorization announced in May 2024.

    "This new share repurchase authorization and the 4.1% increase in our common stock dividend that we announced earlier this month reflect MetLife's financial strength and all-weather performance," said MetLife President and Chief Executive Officer Michel Khalaf. "Altogether, these actions illustrate our commitment to providing an attractive total return for our shareholders as part of our New Frontier strategy."

    About MetLife

    MetLife, Inc. (NYSE:MET), through its subsidiaries and affiliates ("MetLife"), is one of the world's leading financial services companies, providing insurance, annuities, employee benefits and asset management to help individual and institutional customers build a more confident future. Founded in 1868, MetLife has operations in more than 40 markets globally and holds leading positions in the United States, Asia, Latin America, Europe and the Middle East. For more information, visit www.metlife.com.

    Forward-Looking Statements

    The forward-looking statements in this news release, using words such as "commitment," are based on assumptions and expectations that involve risks and uncertainties, including the "Risk Factors" MetLife, Inc. describes in its U.S. Securities and Exchange Commission filings. MetLife's future results could differ, and it does not undertake any obligation to publicly correct or update any of these statements.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250429551598/en/

    For Media:

    Dave Franecki

    (973) 264-7465

    [email protected]

    For Investors:

    John Hall

    (212) 578-7888

    [email protected]

    Get the next $MET alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MET

    DatePrice TargetRatingAnalyst
    1/23/2025$97.00Market Perform
    BMO Capital Markets
    10/9/2024$97.00Buy
    TD Cowen
    9/5/2024$91.00Overweight
    Barclays
    1/8/2024$80.00Neutral → Buy
    Goldman
    11/17/2023$71.00Overweight
    Barclays
    10/5/2023$71.00Hold
    Deutsche Bank
    9/14/2023$58.00 → $72.00Hold → Buy
    Jefferies
    1/9/2023$80.00 → $78.00Buy → Neutral
    Goldman
    More analyst ratings

    $MET
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • MetLife Investment Management Names Brian Funk President

      MetLife Investment Management (MIM), the institutional asset management business of MetLife, Inc. (NYSE:MET), today announced that it has named Brian Funk its president. Funk previously served as interim president and global head of Private Capital for MIM. Funk will be responsible for delivering investment performance and client growth to expand MIM's $616.9 billion in total assets under management (AUM).1 This includes integrating PineBridge Investments, a global asset manager with approximately $100 billion in AUM,2 into the firm, upon closing of the acquisition anticipated to occur by the end of 2025. This acquisition will significantly expand MIM's public and private credit offerings

      6/18/25 4:15:00 PM ET
      $MET
      Life Insurance
      Finance
    • New PPO Dental Plans More Competitive Against HMOs

      LOS ANGELES, June 11, 2025 /PRNewswire/ -- DentalInsurance.com, the leader in dental insurance comparison shopping, has broadened its inventory of PPO dental plans offering high maximum benefits. A maximum benefit is the annual cap on insurance company spending toward a consumer's covered dental care. PPO plans have a maximum benefit limit while HMO dental insurance doesn't. PPOs, however, have much wider dentist networks than most competing HMO plans. This helps consumers receive quality dental care from a trusted preferred dentist. By adding high maximum benefits, a new generation of PPO dental plans have become an even more attractive option for consumers.

      6/11/25 10:07:00 AM ET
      $CI
      $HUM
      $MET
      Medical Specialities
      Health Care
      Life Insurance
      Finance
    • AM Best Assigns Indicative Issue Credit Ratings to MetLife, Inc.'s New Shelf Registration

      AM Best has assigned indicative Long-Term Issue Credit Ratings of "a-" (Excellent) to senior unsecured issues, "bbb+" (Good) to subordinated issues, and "bbb" (Good) to preferred stock to the recently filed shelf registration of MetLife, Inc. (MetLife) (headquartered in New, NY) (NYSE:MET). The outlook assigned to these Credit Ratings (ratings) is stable. Concurrently, AM Best has withdrawn the ratings on the previous shelf registrations, which expired. MetLife's proforma financial leverage and the historical interest coverage ratios are in line with its current ratings, and its holding company liquidity is strong. This press release relates to Credit Ratings that have been published on A

      5/21/25 10:10:00 AM ET
      $MET
      Life Insurance
      Finance

    $MET
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Hubbard Robert Glenn was granted 964 shares, increasing direct ownership by 0.97% to 100,489 units (SEC Form 4)

      4 - METLIFE INC (0001099219) (Issuer)

      6/20/25 4:33:37 PM ET
      $MET
      Life Insurance
      Finance
    • Director Johnson Jeh C. was granted 562 shares, increasing direct ownership by 9% to 6,789 units (SEC Form 4)

      4 - METLIFE INC (0001099219) (Issuer)

      6/20/25 4:33:17 PM ET
      $MET
      Life Insurance
      Finance
    • Director Morrison Denise M was granted 562 shares, increasing direct ownership by 2% to 32,817 units (SEC Form 4)

      4 - METLIFE INC (0001099219) (Issuer)

      6/20/25 4:33:06 PM ET
      $MET
      Life Insurance
      Finance

    $MET
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • BMO Capital Markets initiated coverage on MetLife with a new price target

      BMO Capital Markets initiated coverage of MetLife with a rating of Market Perform and set a new price target of $97.00

      1/23/25 7:50:09 AM ET
      $MET
      Life Insurance
      Finance
    • TD Cowen initiated coverage on MetLife with a new price target

      TD Cowen initiated coverage of MetLife with a rating of Buy and set a new price target of $97.00

      10/9/24 7:52:22 AM ET
      $MET
      Life Insurance
      Finance
    • Barclays initiated coverage on MetLife with a new price target

      Barclays initiated coverage of MetLife with a rating of Overweight and set a new price target of $91.00

      9/5/24 8:14:53 AM ET
      $MET
      Life Insurance
      Finance